Advanced Vision Care Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2020
NCT04521140
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Advanced Vision Care | Nicole Fram M.D.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Corneal Edema (Phase 4)

Inflammation (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 4